Dallah Healthcare Company (TADAWUL:4004)
Saudi Arabia · Delayed Price · Currency is SAR 58.75
-0.25 (-0.42%)
Nov 5, 2026, 3:18 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Buy" and an average price target of SAR 102.86. The average 1-year stock price forecast is 75.08% higher than the current stock price, while the lowest is SAR 85.00 (+44.68%) and the highest is SAR 133.33 (+126.94%).
Price Target: SAR 102.86 (+75.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 3 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 3 | 6 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 10 | 10 |
Financial Forecast
Revenue This Year
4.51B
from 4.07B
Increased by 10.82%
Revenue Next Year
5.01B
from 4.51B
Increased by 11.08%
EPS This Year
4.98
from 4.43
Increased by 12.36%
EPS Next Year
4.70
from 4.98
Decreased by -5.65%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.